Nurix Therapeutics (NRIX) Stock Forecast & Price Target

$22.92 -3.94 (-14.67%)

(As of 11/15/2024 ET)

Nurix Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
1

Buy
14

Based on 15 Wall Street analysts who have issued ratings for Nurix Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a hold rating, and 14 have given a buy rating for NRIX.

Consensus Price Target

$29.40
28.27% Upside

According to the 15 analysts' twelve-month price targets for Nurix Therapeutics, the average price target is $29.40. The highest price target for NRIX is $41.00, while the lowest price target for NRIX is $10.00. The average price target represents a forecasted upside of 28.27% from the current price of $22.92.

NRIX Analyst Ratings Over Time

Type	Current Forecast 11/16/23 to 11/15/24	1 Month Ago 10/17/23 to 10/16/24	3 Months Ago 8/18/23 to 8/17/24	1 Year Ago 11/16/22 to 11/16/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	13 Buy rating(s)	12 Buy rating(s)	8 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$29.40	$28.71	$26.69	$28.75
Forecasted Upside	28.27% Upside	11.25% Upside	19.80% Upside	373.64% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

Top "Sleeping Giant" Crypto In The Market Now (Ad)

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late

NRIX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NRIX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nurix Therapeutics Stock vs. The Competition

Type	Nurix Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.93	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	28.27% Upside	28,186.82% Upside	9.93% Upside
News Sentiment Rating	Very Positive News See Recent NRIX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/6/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$29.00 ➝ $29.00	+14.04%
10/24/2024	UBS Group 4 of 5 stars	D. Dai Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$35.00	+41.24%
10/21/2024	HC Wainwright 2 of 5 stars		Boost Target	Buy ➝ Buy	$26.00 ➝ $30.00	+19.76%
10/14/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$27.00 ➝ $26.00	+9.47%
10/14/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Loganathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$31.00 ➝ $31.00	+28.10%
10/11/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$41.00	+87.56%
Top "Sleeping Giant" Crypto In The Market Now (Ad) Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late
9/6/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$26.00	+6.38%
9/4/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$27.00 ➝ $30.00	+22.30%
7/31/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Devarakonda Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$36.00	+73.33%
7/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$31.00 ➝ $34.00	+43.10%
7/15/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$20.00 ➝ $31.00	+29.17%
6/5/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$35.00 ➝ $35.00	+113.94%
5/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$27.00	+80.60%
2/26/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $10.00	-11.35%
2/16/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$23.00 ➝ $20.00	+100.80%
12/13/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$37.00 ➝ $28.00	+126.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:29 PM ET.

NRIX Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Nurix Therapeutics is $29.40, with a high forecast of $41.00 and a low forecast of $10.00.
: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nurix Therapeutics in the last year. There is currently 1 hold rating and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NRIX shares.
: According to analysts, Nurix Therapeutics's stock has a predicted upside of 28.27% based on their 12-month stock forecasts.
: Nurix Therapeutics has been rated by research analysts at HC Wainwright, Jefferies Financial Group, Needham & Company LLC, Oppenheimer, Robert W. Baird, Royal Bank of Canada, Stephens, and UBS Group in the past 90 days.
: Analysts like Nurix Therapeutics more than other "medical" companies. The consensus rating score for Nurix Therapeutics is 2.93 while the average consensus rating score for "medical" companies is 2.80. Learn more on how NRIX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Top "Sleeping Giant" Crypto In The Market Now (Ad)

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late

This page (NASDAQ:NRIX) was last updated on 11/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nurix Therapeutics (NRIX) Stock Forecast & Price Target